GSEA results also showed that patients with high SOX9 expression had enrichment for the TGF-β signaling pathway and pathway in cancer (Figure 2B), while the low SOX9 expression group had enrichment for the primary immunodeficiency pathway and the T cell receptor signaling pathway (Supplementary Figure 1). The gene discussed is SOX9; the disease is cancer.